[...] from the Merck Serono division to the Consumer Health division. A detailed presentation of the resulting disclosure changes in segment reporting can be found in the information on segment reporting. The notes to the consolidated financial statements of the Merck Group for 2013, particularly the accounting policies, apply accordingly. Income tax include the taxes on taxable profit levied in the individual countries plus changes in deferred taxes recognized in income. The income tax in the interim financial statements is calculated based on the income of the consolidated companies and the currently valid tax rate as a best possible estimate. The preparation of the [...]
[...] 2,863.1 2,841.1 0.8 5,527.9 5,601.6 –1.3 Sales 2,795.5 2,743.9 1.9 5,409.4 5,404.3 0.1 Operating result (EBIT) 441.0 465.4 –5.2 909.3 864.8 5.1 Margin (% of sales) 15.8 17.0 16.8 16.0 EBITDA 767.0 793.1 –3.3 1,537.2 1,546.9 –0.6 Margin (% of sales) 27.4 28.9 28.4 28.6 EBITDA pre one-time items 845.7 826.4 2.3 1,652.7 1,627.5 1.6 Margin (% of sales) 30.3 30.1 30.6 30.1 Earnings per share (€)1 0.70 0.73 –4.1 1.45 1.34 8.2 Earnings per share pre one-time items (€)1 1.16 1.13 2.7 2.32 2.19 5.9 Business free cash flow 632.2 783.8 –19.3 1,316.3 1,376.7 –4.4 Development of sales and results of operations In the second quarter of 2014, sales of the Merck [...]
XLS Performance Materials | Key figures € million Q2 – 2014 Q2 – 2013 Change in % Jan.–June 2014 Jan.–June 2013 Change in % Total revenues 505.9 431.8 17.2 908.6 853.9 6.4 Sales 505.7 431.1 17.3 907.9 852.4 6.5 Operating result (EBIT) 137.5 170.1 –19.2 289.2 342.7 –15.6 Margin (% of sales) 27.2 39.5 31.8 40.2 EBITDA 178.1 205.1 –13.2 356.9 408.4 –12.6 Margin (% of sales) 35.2 47.6 39.3 47.9 EBITDA pre one-time items 226.3 208.9 8.3 412.8 416.3 –0.9 Margin (% of sales) 44.8 48.5 45.5 48.8 Business free cash flow 179.4 201.9 –11.1 344.9 400.9 –14.0 Development of sales and results of operations In the second quarter of 2014, sales of the [...]
XLS Merck Millipore | Key figures € million Q2 – 2014 Q2 – 2013 Change in % Jan.–June 2014 Jan.–June 2013 Change in % Total revenues 661.5 668.7 –1.1 1,321.9 1,343.3 –1.6 Sales 658.7 666.3 –1.1 1,315.2 1,335.0 –1.5 Operating result (EBIT) 75.2 72.4 3.8 162.2 144.8 12.1 Margin (% of sales) 11.4 10.9 12.3 10.8 EBITDA 150.3 148.2 1.4 314.0 299.7 4.8 Margin (% of sales) 22.8 22.2 23.9 22.5 EBITDA pre one-time items 165.7 155.9 6.3 335.4 317.8 5.5 Margin (% of sales) 25.2 23.4 25.5 23.8 Business free cash flow 125.5 156.6 –19.9 179.9 237.7 –24.3 Development of sales and results of operations Despite a challenging market environment characterized by [...]
XLS Consumer Health | Key figures € million Q2 – 2014 Q2 – 20131 Change in % Jan.–June 2014 Jan.–June 20131 Change in % 1 The previous year’s figures have been adjusted, see “The Merck Group and its divisions”. Total revenues 185.0 180.1 2.7 365.6 361.9 1.0 Sales 184.7 178.9 3.3 364.9 360.6 1.2 Operating result (EBIT) 36.9 34.2 7.9 73.7 71.0 3.8 Margin (% of sales) 20.0 19.1 20.2 19.7 EBITDA 39.3 36.5 7.6 78.4 76.0 3.3 Margin (% of sales) 21.3 20.4 21.5 21.1 EBITDA pre one-time items 41.4 35.5 16.7 82.6 74.8 10.5 Margin (% of sales) 22.4 19.8 22.6 20.7 Business free cash flow 36.2 50.9 –28.9 52.4 71.8 –27.0 Development of sales and results of [...]
